dc.contributor.author | Pavlidis, Nicholas | en |
dc.contributor.author | Bairaktari, Eleni Th | en |
dc.contributor.author | Kalef-Ezra, J. A. | en |
dc.contributor.author | Nikolaides, C. | en |
dc.contributor.author | Briassoulis, E. Ch | en |
dc.contributor.author | Seferiadis, C. | en |
dc.contributor.author | Fountzilas, George | en |
dc.creator | Pavlidis, Nicholas | en |
dc.creator | Bairaktari, Eleni Th | en |
dc.creator | Kalef-Ezra, J. A. | en |
dc.creator | Nikolaides, C. | en |
dc.creator | Briassoulis, E. Ch | en |
dc.creator | Seferiadis, C. | en |
dc.creator | Fountzilas, George | en |
dc.date.accessioned | 2018-06-22T09:54:15Z | |
dc.date.available | 2018-06-22T09:54:15Z | |
dc.date.issued | 1994 | |
dc.identifier.uri | https://gnosis.library.ucy.ac.cy/handle/7/42266 | |
dc.description.abstract | The levels of CA 19-9, CA 15-3 and CA 125 in the serum of 50 patients with non-Hodgkin's lymphomas (NHL) were investigated. Mean values of these serum tumor markers were compared to stage, presence or absence of B-symptoms, histology and site of the disease. Increased serum levels were detected in 20%-28% of the patients. However, statistical significant difference was found only in the levels of CA 125 as compared to the advanced stage (p < 0.05) and especially in those patients with abdominal (p < 0.05) and mediastinal involvement (p < 0.01). We conclude that more elevated CA 125 levels can be found in the serum of patients with advanced NHL and more commonly in those with extensive internal lymphadenopathy. | en |
dc.language.iso | eng | en |
dc.source | Journal of Experimental and Clinical Cancer Research | en |
dc.subject | Article | en |
dc.subject | Human | en |
dc.subject | Adult | en |
dc.subject | Aged | en |
dc.subject | Female | en |
dc.subject | Major clinical study | en |
dc.subject | Priority journal | en |
dc.subject | Nonhodgkin lymphoma | en |
dc.subject | Male | en |
dc.subject | Tumor marker | en |
dc.subject | Cancer epidemiology | en |
dc.subject | Ca 125 antigen | en |
dc.subject | Ca 15-3 antigen | en |
dc.subject | Ca 19-9 antigen | en |
dc.subject | Non-hodgkin's lymphomas | en |
dc.subject | Serum ca 125 | en |
dc.title | The value of CA-125 determination in the serum of patients with non-Hodgkin's lymphomas. A preliminary report | en |
dc.type | info:eu-repo/semantics/article | |
dc.description.volume | 13 | |
dc.description.issue | 2 | |
dc.description.startingpage | 135 | |
dc.description.endingpage | 138 | |
dc.author.faculty | Ιατρική Σχολή / Medical School | |
dc.author.department | Ιατρική Σχολή / Medical School | |
dc.type.uhtype | Article | en |
dc.contributor.orcid | Pavlidis, Nicholas [0000-0002-2195-9961] | |
dc.gnosis.orcid | 0000-0002-2195-9961 | |